{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7ezpcIDA","lastupdate":"2024-09-02T00:00:00.000Z","update_date":"2024-09-02T00:00:00.000Z","lastModified":"Sep 21, 2024","active":1,"confidence_score":90,"confidence_score_reason":"markets, not claimed","urlname":"valcare-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$PAvyo4rrQnly2LuCnclNyRpiym8uhp3mLD2lh3uyVX1meN7s5BEzNv","name":"ValCare Medical","oneliner":"Minimally Invasive Treatment for Valve Disease","registrar":"514791656","website":"https://www.valcaremedical.com","careerspage":"","founded_month":6,"founded_year":2012,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCIZmvOtOceHOD8cWLpoYwyw","facebook":"","linkedin":"https://www.linkedin.com/company/18263093","instagram":""},"social":["https://www.youtube.com/channel/UCIZmvOtOceHOD8cWLpoYwyw","https://www.linkedin.com/company/18263093"],"flattenedsociallinks":"https://www.youtube.com/channel/UCIZmvOtOceHOD8cWLpoYwyw|https://www.linkedin.com/company/18263093","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"11-50","employees_exact":30,"patent":1,"raised":23000000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":[""],"about":"Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve and repair of the tricuspid valve. The company’s breakthrough mitral valve treatment platform is based on a D-shaped ring that serves as both a highly effective tool for mitral annulus repair and a docking station for Valcare’s exclusive replacement prosthesis.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972732315090","country":null,"address":{"israeli":[{"id":"4bc94099-4c48-469a-97dd-eb261006318e","city":"Herzliya","type":null,"address":"Maskit 2, Herzliyya, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"myWAj3Ck3PCuMLq7EY0CmCPuslbqc29zMoYMC1gE9rXyu6j1qbIMJW","date":"Jul 2, 2024","link":"https://www.prnewswire.com/news-releases/valcare-medical-inc-announces-formation-of-scientific-advisory-board-with-renowned-mitral-valve-experts-302187660.html","source":"www.prnewswire.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"vDC9qxNwPMxBLYLujlzzEZ2foDSMwiU9UnVCmY5xGWDsvlbBFlYpiC","news_summary":"Valcare Medical, Inc. Announces Formation of Scientific Advisory Board with Renowned Mitral Valve Experts","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"PkAfjwr5VJxek43RxxGpmRNbsDoeaGekn0bio9F8xRPPjwGaXieWcE","date":"May 13, 2024","link":"https://www.prnewswire.com/news-releases/valcare-medical-announces-enrollment-of-first-two-patients-in-amend-ts-eu-pilot-study-302143860.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"pilot study","company":"Valcare Medical, Inc.","layoffs":null,"summary":"Valcare Medical, Inc. announced the successful completion of the first two enrollments in the AMEND TS European pilot study. The study aims to evaluate the safety and performance of the AMEND Trans-Septal System for mitral repair. Dr. Bruno Melica and his team at Vila Nova de Gaia Hospital in Portugal performed the procedures. The study will enroll 20 patients across several European sites and follow them for 12 months. This marks a significant advancement for Valcare Medical in addressing high-risk mitral valve surgery patients. The AMEND device is investigational and not yet available for commercial use.","partners":[],"customers":["Vila Nova de Gaia Hospital"],"investors":[],"confidence":10,"key_topics":["enrollment","mitral repair","pilot study","innovation","safety"],"date_of_event":"May 14, 2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HaFFKgtY8fmqY801buCI7hhsX1Alh7sZVq3MQayNsPNBIrVdLOpf6h","news_summary":"Valcare Medical Announces Enrollment of First Two Patients in AMEND™ TS EU Pilot Study","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"zOAKRm62hWbIpPQgHx1rYTB9sFMuILBXRXWw5JlIsqCgdmZgVxOiGu","date":"Apr 24, 2024","link":"https://www.prnewswire.com/news-releases/valcare-medical-inc-announces-corporate-restructuring-and-appointment-of-new-ceo-302125431.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"restructuring","company":"Valcare Medical, Inc.","layoffs":null,"summary":"Valcare Medical, Inc., a leader in transcatheter-based mitral solutions, announced a corporate restructuring led by Techwald Next. The restructuring aims to accelerate the companys plans for clinical studies in Europe and the U.S. Steve Sandweg has been appointed as the new CEO, bringing extensive experience in the medical device sector. The company also appointed a new Board of Directors led by Chris Richardson. The restructuring is expected to enhance focus and performance, particularly in the development and clinical trials of the AMEND mitral valve repair device.","partners":null,"customers":null,"investors":["Techwald Next"],"confidence":10,"key_topics":["restructuring","clinical studies","new CEO","board changes","mitral solutions"],"date_of_event":"Not specified","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kA0fNP3Y4gDESZ9lMdmgl9sgSURPGcd23FXZMICq0Wk9NGLbTKLJME","news_summary":"Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7586489c-a76a-482b-862e-737572353680","date":"Jan 27, 2021","link":"https://www.prnewswire.com/news-releases/valcare-medical-announces-first-in-human-transseptal-implant-of-the-amend-annuloplasty-ring-for-mitral-valve-repair-301216491.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":["transcatheter mitral and tricuspid valve repair","AMEND annuloplasty ring","transseptal delivery","clinical study","FDA early feasibility study"],"company":"Valcare Medical Ltd.","layoffs":null,"summary":"Valcare Medical Ltd. has successfully completed its first-in-human transseptal delivery of the AMEND annuloplasty ring. The procedure was performed at the Schulich Heart Centre in Toronto. The AMEND ring is an innovative mitral repair annuloplasty ring that provides a safer and easier catheter-based treatment option. Valcare will soon begin enrolling patients for its AMEND Plus pilot clinical study and launch an FDA early feasibility study. The AMEND device is limited to investigational use and is not commercially available.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["transcatheter mitral and tricuspid valve repair","AMEND annuloplasty ring","transseptal delivery","clinical study","FDA early feasibility study"],"date_of_event":"January 27, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"faktYFrD4ZORqUZOON0Y10KiGDisgGi6MitBvoWiOOJ10nKYz8YNgv","news_summary":"Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ab5b8fdf-90a2-4b6a-b3fb-36bde8db5998","date":"Jun 20, 2016","link":"http://www.massdevice.com/valcare-touts-1st-human-use-amend-annulplasty-ring/","source":"www.massdevice.com","visible":1,"analysis":{"tags":"medical devices","company":"Valcare Medical","layoffs":null,"summary":"Valcare Medical has announced the successful implantation of its Amend mitral valve repair annuloplasty ring in the first phase of its clinical trial. The device is designed to repair the mitral valve and reduce valvular incompetence. The company also appointed a new CEO, Shuki Porath, while the former CEO will become the CTO.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Amend mitral valve repair annuloplasty ring","clinical trial","transapical delivery system","new CEO","former CEO becomes CTO"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Management Changes"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"kg9ESovSzYVHre6a41KwUpke4bAsyAlKXQ7UF9t6gvfBAWM1l5q3vd","news_summary":"Valcare touts 1st-in-human use of Amend annulplasty ring","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"665d5d1f-abd8-4e36-b103-4774784eddd9","date":"Jul 11, 2012","link":"http://www.globes.co.il/en/article-1000764830","source":"www.globes.co.il","visible":1,"analysis":{"tags":"investment, expand","company":"ValCare Medical Inc.","layoffs":null,"summary":"ValCare Medical Inc., a spinoff of MiCardia Corporation, is receiving an $8 million investment from Accelmed. ValCare is developing a heart valve repair device that is implanted minimally invasively by catheter. The company aims to create a transcatheter mitral valve repair system. The investment will be used to set up a development center in Israel. ValCares CEO, Sam Shaolian, is a former Israeli and the primary inventor of the technology. The market for mitral valve repair is estimated to be worth $3.5 billion per year in the US.","partners":null,"customers":null,"investors":"Moshe (Mori) Arkin and Dr. Uri Geigers Accelmed","confidence":9,"key_topics":["ValCare Medical","investment","development center","transcatheter technology","heart valve repair device"],"date_of_event":"July 11, 2012","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$8 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QW6nmKyLhn1hZpeetBMxKtsdBdLaDLSTEMamLujOQR08gzmoRGPHBE","news_summary":"Accelmed invests $8m in US catheter co ValCare","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":6,"techcommunityinvolvement":null,"mediagallery":[{"id":"56c2a94f-dd46-41a1-8f5e-1b1a0927d081","timestamp":"2016-04-20 13:31:27.000000","resources_type":2,"resources_title":"","resources_file_name":"tQY-BJZpKKw","alt":"","imageurl":"https://img.youtube.com/vi/tQY-BJZpKKw/0.jpg","url":"http://youtu.be/tQY-BJZpKKw"},{"id":"9458524f-a806-4cfd-8f83-e93ce9a94ac8","timestamp":"2015-04-27 11:08:15.000000","resources_type":1,"resources_title":"","resources_file_name":"$b9XOFbcTbc2hzSHFKjUqGDHBGpadWDex4HU3mYcs8btRW4gPi6qrJw","alt":"","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$b9XOFbcTbc2hzSHFKjUqGDHBGpadWDex4HU3mYcs8btRW4gPi6qrJw","url":"https://storage.googleapis.com/clean-finder-353810/$b9XOFbcTbc2hzSHFKjUqGDHBGpadWDex4HU3mYcs8btRW4gPi6qrJw"}],"tags":["surgery","valves","catheters","medical-devices","minimally-invasive","cardiology","surgeons","hospitals","treatments"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["Corona","Trivid","Amend"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":4,"lastfunding":"Undisclosed","totalrounds":3,"fundingstage":"Seed","totalfunding":"$23M","publicinvestors":4,"lastpublicfunding":0,"totalpublicrounds":3,"totalpublicfunding":23000000},"team":[{"name":"Steve Sandweg","email":"ssandweg@valcaremedical.com","phone":"","gender":"Male","userid":"i2HAVBlq5FwozmN8QZfy6Bb7slFf3tyUVPkTBjkxpU3V6SeIldPIr2","bounced":false,"claimed":null,"founder":0,"urlname":"steve-sandweg","visible":1,"memberid":"ugQ0DOyh10XGCf2r7nIAVENL7tTU9wQWlZSyQ6owIze3PT9800RNjX","position":"CEO","last_name":"Sandweg","claimtoken":"yYtThu3JHbqP6Z3AIRnSHZXRdHcQlEiibaQBQDxnhpbhaQI412qzh1","first_name":"Steve","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/steve-sandweg-3429b31b/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-09-02 12:52:20.000000","initials":"SS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Samuel  Shaolian","email":"sshaolian@valcaremedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoLKo6IEKDA","bounced":false,"claimed":0,"founder":1,"urlname":"samuel-shaolian","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgsoypnwoM","position":"Founder & CTO","last_name":"Shaolian","claimtoken":"ntnuWrQIeu3QtQXtZZouZuwIQ58RGhmcL7Ow2ZApMw6cYHVQFRviz8","first_name":"Samuel ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/samshaolian/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-11-10 02:29:46.000000","initials":"SS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Nadav  Yellin","email":"nyellin@valcaremedical.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPHZjfYJDA","bounced":false,"claimed":null,"founder":0,"urlname":"nadav-yellin","visible":1,"memberid":"vbvLj3LTukRnti86D4NEibJhw9ukqWr3cn4zUgaEo8hDzovzY7VIQm","position":"General Manager","last_name":"Yellin","claimtoken":"uNQby6X2XCgTmbEsAxnuJsX80J4UvBZASi9Mn44P2tuwnJcCZ6w6r8","first_name":"Nadav ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/nadav-yellin-01b6a523/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-09-02 12:54:58.000000","initials":"NY","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-04-05T00:00:00.000Z","crunchbaseid":"valcare-medical","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":null,"creator_email":null,"createdate":"2014-11-03T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"14kJgiaBS1XhdkeoP3r04HASvvsL3VD1ZRoGb5TFf3v6iO0f4ci2Z5","date":"Nov 2023","amount":"Undisclosed","source":"https://www.techwald.com/companies/, Rasham, round type from PB","eventtype":"FundingRoundEvent","investment":[{"name":"TechWald Holding","type":"Investor","amount":null,"hidden":false,"country":"Italy","fullurl":"/investor_page/techwald-holding","logokey":"$irgXZPBIUR1fcBBvocm7ENem3YhUwNjjYjYSTuq1uaXbIepYPvJYyF","tagline":"","urlname":"/investor_page/techwald-holding","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCw5cHJCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"C89dqPmPyyeuP1GzHxNgPCVjqOkJtG1Kos6e2WBspKooR6XrkTKZPQ","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$irgXZPBIUR1fcBBvocm7ENem3YhUwNjjYjYSTuq1uaXbIepYPvJYyF","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Private","fundingtypefundingtype":"Secondary Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"private-visibility","fundingvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwIeaCww","date":"Sep 2018","amount":"$15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4e82a6c4-797f-46c9-86d1-9d2205dcd6c6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Shanghai MicroPort CardioFlow Medtech ","type":"Company","amount":0,"hidden":true,"country":"China","fullurl":"/company_page/shanghai-microport-cardioflow-medtech","logokey":"$wHCnOMaW9Q0jqe0DsT6WnI5ZOxe9dwwEOHxLhIx13c2afJQOrAXgOr","tagline":"Advanced Minimally Invasive Therapies for Structural Heart Diseases","urlname":"/company_page/shanghai-microport-cardioflow-medtech","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtfqMCww","fundingtype":"Company","leadpartner":null,"investmentid":"79cab566-59c4-4cf1-8645-54e06c4db813","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wHCnOMaW9Q0jqe0DsT6WnI5ZOxe9dwwEOHxLhIx13c2afJQOrAXgOr","leadcaption":"","followupcaption":""},{"name":"HBM Healthcare Investments","type":"Investor","amount":0,"hidden":false,"country":"Switzerland","fullurl":"/investor_page/hbm-healthcare-investments","logokey":"$TccGB9WBfYLdfaW1TZuIYYv2bVYjON3XMWFv9xBbWbGcyzFOaWbqYd.jpeg","tagline":"","urlname":"/investor_page/hbm-healthcare-investments","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjdPQCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"958b54ff-55ff-4186-b5ab-60299c7d64a1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TccGB9WBfYLdfaW1TZuIYYv2bVYjON3XMWFv9xBbWbGcyzFOaWbqYd.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWBCgw","date":"Jul 2012","amount":"$8M","source":"https://en.globes.co.il/en/article-1000764830","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":8000000,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f07db530-8a91-4183-ba03-d683bef615fa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2012","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"ValCare Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$PAvyo4rrQnly2LuCnclNyRpiym8uhp3mLD2lh3uyVX1meN7s5BEzNv","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$PAvyo4rrQnly2LuCnclNyRpiym8uhp3mLD2lh3uyVX1meN7s5BEzNv","seoabout":"Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product l...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Medical Devices","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Implants","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Implants"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Medical Devices","Medical Treatment & Therapeutics"],"coreTechnology":["Materials & Substances","Implants"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"14kJgiaBS1XhdkeoP3r04HASvvsL3VD1ZRoGb5TFf3v6iO0f4ci2Z5","date":"Nov 2023","amount":"Undisclosed","source":"https://www.techwald.com/companies/, Rasham, round type from PB","eventtype":"FundingRoundEvent","investment":[{"name":"TechWald Holding","type":"Investor","amount":null,"hidden":false,"country":"Italy","fullurl":"/investor_page/techwald-holding","logokey":"$irgXZPBIUR1fcBBvocm7ENem3YhUwNjjYjYSTuq1uaXbIepYPvJYyF","tagline":"","urlname":"/investor_page/techwald-holding","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCw5cHJCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"C89dqPmPyyeuP1GzHxNgPCVjqOkJtG1Kos6e2WBspKooR6XrkTKZPQ","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$irgXZPBIUR1fcBBvocm7ENem3YhUwNjjYjYSTuq1uaXbIepYPvJYyF","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Private","fundingtypefundingtype":"Secondary Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"private-visibility","fundingvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkwIeaCww","date":"Sep 2018","amount":"$15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4e82a6c4-797f-46c9-86d1-9d2205dcd6c6","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Shanghai MicroPort CardioFlow Medtech ","type":"Company","amount":0,"hidden":true,"country":"China","fullurl":"/company_page/shanghai-microport-cardioflow-medtech","logokey":"$wHCnOMaW9Q0jqe0DsT6WnI5ZOxe9dwwEOHxLhIx13c2afJQOrAXgOr","tagline":"Advanced Minimally Invasive Therapies for Structural Heart Diseases","urlname":"/company_page/shanghai-microport-cardioflow-medtech","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEtfqMCww","fundingtype":"Company","leadpartner":null,"investmentid":"79cab566-59c4-4cf1-8645-54e06c4db813","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wHCnOMaW9Q0jqe0DsT6WnI5ZOxe9dwwEOHxLhIx13c2afJQOrAXgOr","leadcaption":"","followupcaption":""},{"name":"HBM Healthcare Investments","type":"Investor","amount":0,"hidden":false,"country":"Switzerland","fullurl":"/investor_page/hbm-healthcare-investments","logokey":"$TccGB9WBfYLdfaW1TZuIYYv2bVYjON3XMWFv9xBbWbGcyzFOaWbqYd.jpeg","tagline":"","urlname":"/investor_page/hbm-healthcare-investments","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEjdPQCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"958b54ff-55ff-4186-b5ab-60299c7d64a1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TccGB9WBfYLdfaW1TZuIYYv2bVYjON3XMWFv9xBbWbGcyzFOaWbqYd.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWBCgw","date":"Jul 2012","amount":"$8M","source":"https://en.globes.co.il/en/article-1000764830","eventtype":"FundingRoundEvent","investment":[{"name":"Accelmed","type":"Investor","amount":8000000,"hidden":false,"country":"Israel","fullurl":"/investor_page/accelmed","logokey":"$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","tagline":null,"urlname":"/investor_page/accelmed","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKmI44gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f07db530-8a91-4183-ba03-d683bef615fa","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$FaEkBoI4nadGPZmOWfS9cEXuO0HvFoMp6AH9slrWmX4uk0dGvZ4xSj","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":8000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}